Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020

Detalles Bibliográficos
Autores principales: Van Oekelen, Oliver, Birrer, Nicole, Wesson, William, Galate, Vincent L., Cliff, Edward R. Scheffer, Goodman, Aaron M., Abdallah, Al-Ola, Chakraborty, Rajshekhar, Prasad, Vinay, Mohyuddin, Ghulam Rehman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666639/
https://www.ncbi.nlm.nih.gov/pubmed/36379917
http://dx.doi.org/10.1038/s41408-022-00750-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666639/
https://www.ncbi.nlm.nih.gov/pubmed/36379917
http://dx.doi.org/10.1038/s41408-022-00750-1

Ejemplares similares